Search results

The new protein production platform will start in the beginning 2022 and is a co-operation between five Swedish universities. A new nationally distributed infrastructure - Protein Production Sweden or Proteinproduktion Sverige (PPS) in Swedish, will start up in the beginning of 2022. This is made possible thanks to a five-year-grant (until 2026) from the Swedish Research Council. Together, five un

https://www.lp3.lu.se/article/new-national-infrastructure-protein-production-sweden-pps - 2026-06-27

LP3 extends its portfolio of machines available for biophysical analysis by welcoming the OMNISEC system from Malvern Panalytical. Thanks to a grant from Olle Engkvisits foundation to Prof. Anders Malmström (Experimental Medical Sciences, Lund University), we now host a state of the art multi-detection size exclusion chromatography (SEC) system: OMNISEC. The OMNISEC system is now available to user

https://www.lp3.lu.se/article/now-lp3-absolute-molecular-weight-determination-proteins - 2026-06-27

Wolfgang Knecht, head of LP3 presented the capabilities of LP3 in biophysics and protein structure determination at the first Swedish national PI-meeting in Biochemistry, Biophysics and Molecular Biology (external webpage). The meeting was jointly organized by the Swedish Society for Biochemistry, Biophysics and Molecular Biology, SFBBM(external webpage, in Swedish) and the Swedish National Commit

https://www.lp3.lu.se/article/lp3-presented-swedish-national-pi-meeting-biochemistry-biophysics-and-molecular-biology - 2026-06-27

To strengthen the engagement of the Swedish scientific community in ESS, Sweden has now officially become part of the ESS in-kind community with four projects selected by ESS and the Swedish Research Council. To strengthen the engagement of the Swedish scientific community in the European Spallation Source (ESS), Sweden has now officially become part of the ESS in-kind community with a number of c

https://www.lp3.lu.se/article/sweden-enters-kind-agreement-ess-lp3-contributes-deuteration-lab-services - 2026-06-27

The Deuteration Network (DeuNet) is an international network which aims to facilitate access to deuteration services. The Deuteration Network (DeuNet) (external webpage) is an international network of deuteration facilities and laboratories which aims to facilitate access to deuteration services and customised deuterium labelling of molecules and biomolecules for use in neutron research and in oth

https://www.lp3.lu.se/article/new-deunet-webpage-now-launched - 2026-06-27

All staff from LP3, which is one out of five nodes in the PPS national infrastructure, participated. The distributed national research infrastructure Protein Production Sweden (PPS, see external website) did meet for its second annual staff retreat at Ljunglöfska slottet in Stockholm. The 25 staff researchers of PPS attending used the two day meeting (28/29th September 2023) to discuss and reflect

https://www.lp3.lu.se/article/annual-pps-retreat-stockholm - 2026-06-27

Recently, a book chapter with protocols for the Baculovirus Expression Vector System in insect cells was published by LP3. Lund Protein Production Platform (LP3) has recently published its standard operating procedures for recombinant protein expression using the Baculovirus Expression Vector System (BEVS) in insect cells. Read the full book chapter here at Springer Link (external website)LP3 prov

https://www.lp3.lu.se/article/new-publication-about-bevs-lp3 - 2026-06-27

Members of the board and scientific committee of PPS, Sabine Suppmann and Kim Remans, respectively are among the authors of a new review in Star Protocols about expression systems for recombinant protein production. The overview is based on a survey with 60 leading experts in protein production about their experiences and practices in using different expression systems for recombinant protein prod

https://www.lp3.lu.se/article/guide-choosing-expression-system-recombinant-proteins - 2026-06-27

Lund Protein Production Platform (LP3) is featured in EUGLOHRIA Talks and EUGLOHRIA Virtual Tours approaching audiences with interactive and innovative content and an interview with the head of LP3, Dr. Wolfgang Knecht, is now available on the EUGLOHRIA homepage. The European University Alliance for Global Health – Transformation through Joint Research and Innovation Action (EUGLOHRIA, external li

https://www.lp3.lu.se/article/lund-protein-production-platform-featured-euglohria-talks-and-euglohria-virtual-tours - 2026-06-27

At the first 2024 management meeting, SciLifeLab Lund welcomed LP3 as a new local core facility. The aim of the local SciLifeLab sites in Umeå, Linköping, Gothenburg and Lund is to bring national infrastructure activities closer to the research communities at these locations, and to contribute to increased synergies and collaborations with multiple stakeholders.SciLifeLab Lund (external webpage) w

https://www.lp3.lu.se/article/lp3-newest-local-core-facility-scilifelab-lund - 2026-06-27

LP3 with Celeste Sele presented its capabilities in Protein Characterisation, Crystallisation and Structure Determination at the 35th MAX IV user meeting in Lund (external homepage). LP3 is harboring a local node of Protein Production Sweden (PPS). PPS focuses on the production and purification of (mainly) recombinant protein reagents for all Swedish researchers. The Director of PPS, Malin Bäckstr

https://www.lp3.lu.se/article/lp3-and-pps-35th-max-iv-user-meeting - 2026-06-27

LP3 is now part of "Pandemics and Alertness", a collaboration initiative for virus-related topics by Lund University Pandermics and Alertness is an interdisciplinary platform created to promote collaboration and change of information between stakeholders, researchers and experts from different disciplines, and public authorities to improve our knowledge of the impact of pandemics on the society. A

https://www.lp3.lu.se/article/pandemics-and-alertness - 2026-06-27

Together with DEMAX (see external wesite), the Lund Protein Production Platform (LP3) recently published a new protocol for the use of algal autolysate for the production of deuterium-labeled recombinant protein featuring:Continuous cultivation and autolysis of deuterated B. brauniiAutolysate used as glycerol substitute in recombinant protein productionUsing autolysate gives high protein yield and

https://www.lp3.lu.se/article/demax-and-lp3-publish-new-protocol-use-algal-autolysate-production-deuterium-labeled-recombinant - 2026-06-27

InfraLife Project Coordinator, Claire Lyons, came for a site visit at LP3 InfraLife is a national initiative to improve knowledge and availability of infrastructures and make it accessible to Life science researchers in academia, industry and health care. Read more about the visit here at InfraLife news (external webpage).  More information about InfraLife can be found on the InfraLife homepage (e

https://www.lp3.lu.se/article/visit-infralife-lp3 - 2026-06-27

Tidigare forskningsstudier som gjorts har visat på ökad risk att utveckla autoimmun (typ 1) diabetes för barn som fötts med kejsarsnitt. Eftersom TEDDY är en omfattande studie med många deltagare är det intressant att även i TEDDY undersöka om kejsarsnitt i sig påverkar risken att utveckla autoimmun (typ 1) diabetes. För att veta svaret läs vår svenska sammanfattning "Påverkar kejsarsnitt risken a

https://www.teddy.lu.se/artikel/paverkar-kejsarsnitt-risken-att-utveckla-autoimmun-typ-1-diabetes - 2026-06-27

Puberteten är en känslig period då mycket händer i kroppen. Många av de barn som får diagnosen autoimmun (typ 1) diabetes utvecklar sjukdomen just under puberteten. Varför är det så? Det vill forskare på TEDDY ta reda på. Läs vår nya svenska sammanfattning "Hur påverkar puberteten risken att utveckla autoimmun (typ 1) diabetes?" Alla TEDDY-studiens resultat samlas på sidan ”Resultat från TEDDY"

https://www.teddy.lu.se/artikel/hur-paverkar-puberteten-risken-att-utveckla-autoimmun-typ-1-diabetes - 2026-06-27

TEDDY-studien som startade år 2004 håller på att närma sig slutet. Studien har följt barnen som går i studien tills de är 15 år. De flesta har nu fyllt sina 15 år och avslutat studien men några av barnen har kvar sitt sista 15 års besök. TEDDY-studien har lett forskningen framåt vad gäller autoimmun (typ 1) diabetes och fortsätter leda till nya upptäckter. TV4 har gjort ett reportage om studien. S

https://www.teddy.lu.se/artikel/tv4-nyheterna-om-teddy-studien - 2026-06-27

TEDDY-studien var först med att visa att probiotika kan minska risken för IAA (insulin autoantikroppar) som första autoantikropp. Tack vare TEDDY vill forskare titta närmare på om "snälla" magbakterier kan förebygga autoimmun (typ 1) diabetes. Lyssna och se på SVT - Nyheterna, om SINT1A-studien."Ny forskning på Lunds universitet: Hopp om att ”snälla” tarmbakterier ska förebygga diabetes typ 1". (N

https://www.teddy.lu.se/artikel/svt-nyheter-ny-forskning-pa-lunds-universitet - 2026-06-27

Första publikationen om sköldkörteln från TEDDY och vi har Berglind Jonsdottir som första författare samt även många av våra andra forskare här i Sverige.Inom TEDDY-studien har inte bara autoantikroppar vad gäller autoimmun (typ 1) diabetes och celiaki studerats, utan även autoantikroppar mot sköldkörteln. I och med att TEDDY följt barn sedan 3 månaders ålder har TEDDY gjort upptäckter som inte ha

https://www.teddy.lu.se/artikel/forsta-publikationen-om-skoldkorteln-fran-teddy - 2026-06-27

Nu närmar sig året sitt slut och mycket har hänt inom forskningen. Många nyheter från TEDDY har publicerats och kommer fortsätta framöver. Även om TEDDY närmar sig sitt slut och de sista deltagarna lämnar sitt sista blodprov i början av nästa år så kommer forskningen på alla insamlade prover och data att fortsätta.Ni kommer också i fortsättningen att hitta alla publikationer här på hemsidan med sv

https://www.teddy.lu.se/artikel/god-jul-och-gott-nytt-ar - 2026-06-27